Combining Poly(ADP)-Ribose Polymerase Inhibitors With Abiraterone in Castration-Resistant Prostate Cancer: Is Biomarker Testing Necessary?

Emmanuel S. Antonarakis; Wassim Abida

doi:10.1200/JCO.23.00270

Combining Poly(ADP)-Ribose Polymerase Inhibitors With Abiraterone in Castration-Resistant Prostate Cancer: Is Biomarker Testing Necessary?

Emmanuel S. Antonarakis
, Wassim Abida

Medicine - Hematology, Oncology, Transplant

Research output: Contribution to journal › Editorial › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	3291-3294
Number of pages	4
Journal	Journal of Clinical Oncology
Volume	41
Issue number	18
DOIs	https://doi.org/10.1200/JCO.23.00270
State	Published - Jun 20 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Publisher link

10.1200/JCO.23.00270

Find It

Find It at U of M Libraries

Cite this

@article{4109f4efaaa340cf9d12dc7c0475ad92,

title = "Combining Poly(ADP)-Ribose Polymerase Inhibitors With Abiraterone in Castration-Resistant Prostate Cancer: Is Biomarker Testing Necessary?",

author = "Antonarakis, \{Emmanuel S.\} and Wassim Abida",

year = "2023",

month = jun,

day = "20",

doi = "10.1200/JCO.23.00270",

language = "English (US)",

volume = "41",

pages = "3291--3294",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "18",

}

TY - JOUR

T1 - Combining Poly(ADP)-Ribose Polymerase Inhibitors With Abiraterone in Castration-Resistant Prostate Cancer

T2 - Is Biomarker Testing Necessary?

AU - Antonarakis, Emmanuel S.

AU - Abida, Wassim

PY - 2023/6/20

Y1 - 2023/6/20

UR - https://www.scopus.com/pages/publications/85163673948

UR - https://www.scopus.com/pages/publications/85163673948#tab=citedBy

U2 - 10.1200/JCO.23.00270

DO - 10.1200/JCO.23.00270

M3 - Editorial

C2 - 36952642

AN - SCOPUS:85163673948

SN - 0732-183X

VL - 41

SP - 3291

EP - 3294

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 18

ER -

Combining Poly(ADP)-Ribose Polymerase Inhibitors With Abiraterone in Castration-Resistant Prostate Cancer: Is Biomarker Testing Necessary?

UN SDGs

Publisher link

Find It

Other files and links

Cite this